Receipt of National Comprehensive Cancer Network guideline‐concordant prostate cancer care among African American and Caucasian American men in North Carolina
BACKGROUND African Americans have a higher incidence of prostate cancer and experience poorer outcomes compared with Caucasian Americans. Racial differences in care are well documented; however, few studies have characterized patients based on their prostate cancer risk category, which is required t...
Uložené v:
| Vydané v: | Cancer Ročník 119; číslo 12; s. 2282 - 2290 |
|---|---|
| Hlavní autori: | , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
Hoboken, NJ
Wiley-Blackwell
15.06.2013
|
| Predmet: | |
| ISSN: | 0008-543X, 1097-0142, 1097-0142 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Shrnutí: | BACKGROUND
African Americans have a higher incidence of prostate cancer and experience poorer outcomes compared with Caucasian Americans. Racial differences in care are well documented; however, few studies have characterized patients based on their prostate cancer risk category, which is required to differentiate appropriate from inappropriate guideline application.
METHODS
The medical records of a population‐based sample of 777 North Carolina men with newly diagnosed prostate cancer were studied to assess the association among patient race, clinical factors, and National Comprehensive Cancer Network (NCCN) guideline‐concordant prostate cancer care.
RESULTS
African Americans presented with significantly higher Gleason scores (P = .025) and prostate‐specific antigen levels (P = .008) than did Caucasian Americans. However, when clinical T stage was considered as well, difference in overall risk category only approached statistical significance (P = .055). Across risk categories, African Americans were less likely to have surgery (58.1% versus 68.0%, P = .004) and more likely to have radiation (39.0% versus 27.4%, P = .001) compared with Caucasian Americans. However, 83.5% of men received guideline‐concordant care within 1 year of diagnosis, which did not differ by race in multivariable analysis (odds ratio = 0.83; 95% confidence interval = 0.54‐1.25). Greater patient‐perceived access to care was associated with greater odds of receiving guideline‐concordant care (odds ratio = 1.06; 95% confidence interval = 1.01‐1.12).
CONCLUSIONS
After controlling for NCCN risk category, there were no racial differences in receipt of guideline‐concordant care. Efforts to improve prostate cancer treatment outcomes should focus on improving access to the health care system. Cancer 2013;2282–2290. © 2013 American Cancer Society.
Racial differences in prostate cancer care are well‐documented, but few studies characterize patients based on their prostate cancer risk category. In medical record analysis of a population‐based sample of men from North Carolina who had newly diagnosed prostate cancer, receipt of guideline‐concordant care did not differ by patient race after multivariable analysis. |
|---|---|
| Bibliografia: | this issue. 2209–11 First authorship shared by SD Ellis and B Blackard. The University of North Carolina, Chapel Hill Institutional Review Board provided approval and oversight. Participants provided informed consent. We thank the staff, advisory committees, and research subjects for their important contributions. See editorial on pages ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
| ISSN: | 0008-543X 1097-0142 1097-0142 |
| DOI: | 10.1002/cncr.28004 |